College of Pharmacy leadership announcement

From the Provost — March 22, 2023

College of Pharmacy leadership announcement

Dear Colleagues,

I am pleased to share that Deanna L. Kroetz will join The Ohio State University as our next dean of the College of Pharmacy. Deanna joins us from the University of California, San Francisco (UCSF), where she currently serves as professor and chair of the Department of Bioengineering and Therapeutic Sciences in the Schools of Pharmacy and Medicine. 

When she begins her leadership role on September 1, Deanna will provide strategic vision and operational leadership for the academic and scholarly programs at the College of Pharmacy. In addition, she will set priorities for the college and guide it toward its goals of enhancing teaching, research, and clinical practice, while providing excellence in undergraduate, graduate, and professional education.

The College of Pharmacy is ranked seventh in the nation among all schools of pharmacy by U.S. News and World Report, and it has a team consisting of 75 faculty, more than 100 full-time staff, and nearly 1,000 undergraduate, graduate, and professional students. The college is dedicated to advancing the pharmacy profession through discovery, translational science, and patient-centered care across Ohio and around the globe.

At UCSF, Deanna holds the Jere E. Goyan Presidential Chair for the Advancement of Pharmacy and is a professor of bioengineering and therapeutic sciences and of pharmaceutical chemistry. Her research focuses on the application of human genetics tools to understand drug toxicity. Her reverse translational studies of chemotherapy-induced peripheral neuropathy seek to understand how and why certain cancer therapies can cause nerve damage and lead to discomfort, weakness, or numbness to arms, legs, and other parts of the body. Her laboratory has been funded by the National Institutes of Health throughout her career. 

Deanna is passionate about translational science and believes that a more complete understanding of what drives variability in pharmacological responses and toxicity can transform drug therapy and lead to better clinical outcomes.

An Ohio native, Deanna earned her Bachelor of Science in Pharmacy from Ohio State and her PhD in pharmaceutics from the University of Washington. She completed her postdoctoral fellowship with the National Cancer Institute in the Laboratory of Molecular Carcinogenesis. 

To provide seamless leadership until her September 1 start date, Dean Henry Mann has graciously agreed to extend his appointment through August.

I appreciate the diligent, thoughtful, and thorough work of the search advisory committee, and all who participated in the search process. 

Please join me in extending a warm Ohio State welcome to Deanna as she returns home to her alma mater. 


Melissa L. Gilliam
Executive Vice President and Provost